Presentations NCHIV 2019

Session 1: Advances and barriers in optimising HIV care
Plenary:  ART: a changing landscape Prof. Chloe Orkin (Barts Health NHS Trust, London, UK)
Large cost-savings of splitting a single-tablet regimen (STR) to a two-tablet regimen (TTR), containing the same antiretrovirals Piter Oosterhof (OLVG, Amsterdam; Radboudumc, Nijmegen)
Substantial transmission of the M28V resistant associated variant among acute hepatitis C HIV co-infected men-who-have-sex-with-men Stephanie Popping (Erasmus MC, Rotterdam)
HIV as a chronic condition: Experienced burden of living with HIV today among men who have sex with men in the Netherlands Ward van Bilsen (GGD Amsterdam, Amsterdam)
Reasons for late presentation among older MSM in Amsterdam Maarten Bedert (AIGHD; GGD Amsterdam, Amsterdam)
Highlights from the 2019 HIV Monitoring Report Ard van Sighem, Anders Boyd, Colette Smit & Ferdinand Wit (SHM, Amsterdam)

 

Session 2: From conception to infancy and beyond
Plenary:  Challenges and needs for women living with HIV: From conception to infancy Dr. Karoline Aebi-Popp (University Hospital Bern, Switzerland)
White matter hyperintensity expansion in long-term treated perinatally HIV-infected adolescents: a longitudinal neuroimaging study. Malon van den Hof (Amsterdam UMC, UvA, Amsterdam)
Cerebral organoids as a novel 3D cell culture model to investigate the neuropathogenesis of HIV Stephanie Gumbs (UMC Utrecht, Utrecht)

 

Session 3: Science to advance the response
Keynote:  Ending the HIV Pandemic: Challenges and Opportunities Dr. Anthony Fauci (NIH/NIAID, Bethesda, USA)
Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progression Zita Kruize (Amsterdam UMC, UvA, Amsterdam)
Harm reduction revisited: The causal effect of the Dutch approach towards people who inject drugs on HIV infection risk in Amsterdam, the Netherlands Anders Boyd (GGD Amsterdam, Amsterdam)
Sexual behaviour and perceived risk of HIV between 1999 and 2018 among men who have sex with men in Amsterdam, the Netherlands Ganna Rozhnova (UMC Utrecht, Utrecht)
Inducing cell death: an approach to selectively target viral RNA expressing cells to eliminate the HIV-1 reservoir Shringar Rao (Erasmus MC, Rotterdam)
Repurposing of clinically-approved autophagy drugs for combinatory prophylactic and therapeutic HIV-1 therapies Alexandra Cloherty (Amsterdam UMC, UvA, Amsterdam)

 

Session 4: From the bench to the community
Plenary:   Bringing precision to the global HIV response Prof. Wafaa El Sadr (Columbia University, New York, USA)
Antibodies from rabbits immunized with clade B SOSIP trimers can neutralize despite unusual approach angles Marlies van Haaren (Amsterdam UMC, UvA, Amsterdam)
Comparison of monoclonal antibodies induced by HIV-1 envelop glycoprotein immunization and SHIV infection in non-human primates to guide HIV vaccine design Jelle van Schooten (Amsterdam UMC, UvA, Amsterdam)
Frequency and determinants of switching between daily and event-driven PrEP and discontinuing each regimen among men who have sex with men participating in the Amsterdam PrEP demonstration project Liza Coyer (GGD Amsterdam, Amsterdam)
Offering a choice of daily and event-driven PrEP for MSM: a cost-effectiveness analysis Albert Jan van Hoek (RIVM, Bilthoven)
Using a daily mobile application and dried blot spots to measure adherence to event-driven PrEP among participants of the AMPrEP cohort study Vita Jongen (GGD Amsterdam, Amsterdam)

Presentations without consent for publication are not included.